Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Function Oncology has developed a CRISPR-enabled platform that profiles patient tumor cells to identify actionable gene dependencies. This approach moves beyond traditional sequencing by directly measuring gene function, aiming to optimize therapy selection for individual patients. Early results suggest the platform can predict which existing drugs may be most effective for each patient’s tumor profile. The company recently launched with $28M Series A funding and plans broad collaborations with academic centers and healthcare systems to validate its impact at scale. No published clinical trial outcomes yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Function Oncology.